Back

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate

Arora, K.; Rastogi, R.; Arora, N. M.; Parashar, D.; Paliwal, J.; Naqvi, A.; Srivastava, A.; Singh, S. K.; Kalyanaraman, S.; Potdar, S.; Kumar, D.; Arya, V. B.; Bansal, S.; Rautray, S.; Singh, I.; Fengade, P. S.; Kumar, B.; Kundu, P. K.

2020-05-19 biochemistry
10.1101/2020.05.18.099234 bioRxiv
Show abstract

Spike, Envelope and Membrane proteins from the SARS CoV-2 virus surface coat are important vaccine targets. We hereby report recombinant co-expression of the three proteins (Spike, Envelope and Membrane) in a engineered Saccharomyces cerevisiae platform (D-Crypt) and their self-assembly as Virus-like particle (VLP). This design as a multi-antigenic VLP for SARS CoV-2 has the potential to be a scalable vaccine candidate. The VLP is confirmed by transmission electron microscopy (TEM) images of the SARS CoV-2, along with supportive HPLC, Dynamic Light Scattering (DLS) and allied analytical data. The images clearly outline the presence of a "Corona" like morphology, and uniform size distribution.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.